About Us

KOLIBRI is an early-stage deep-tech biotech start-up backed by Entrepreneur First. Its aim is to unlock the potential of gene therapies and next-generation vaccines by rethinking the bioproduction of biologics, starting with viral vectors.

Viral vector manufacturing remains the blocking point to scale up and make gene therapies and viral vector-based vaccines more affordable and accessible.

To that end, KOLIBRI makes large-scale viral vector manufacturing 10x cheaper and 2x faster combining cutting edge techniques in chemical optimisation and acoustics.

Our Job Openings

We have no job openings at the moment!

Don’t see the position of your dreams?

STATION F Job board is always looking for great talent. Go ahead and send an application!

Spontaneous Application